Welcome to the IAM Patent 1000 2016 – The World’s Leading Patent Professionals, the fifth edition of Intellectual Asset Management’s market-leading guide that identifies and profiles leading private practice patent professionals and firms in the world’s key jurisdictions.Read more
The IAM Patent 1000 is unique in being a one-stop resource that focuses exclusively on naming best-in-class patent prosecution, licensing and litigation practitioners on a global basis, as well as expert witnesses in the United States. For five months, a dedicated research team working out of our offices in London and Hong Kong conducted detailed interviews with thousands of private practice lawyers and attorneys based in dozens of countries, as well as the users of their services, in order to identify the practitioners and practices that are considered to excel at providing patent-related legal services. In the United States, we also asked interviewees to name the expert witnesses they turn to when they need world-class input on both damages and technical issues. The firms and individuals listed on the following pages are the results of that research.
All those listed in the IAM Patent 1000 are included because we received substantial positive feedback about them from multiple sources. We do not claim that we have managed to find every top name in every jurisdiction covered; but we are confident that we have included the vast majority, and that everybody who is listed fully deserves the recognition. For a detailed methodology that explains the research process, as well as how the research team decides who should finally be listed, please click here.
In addition to the listings and editorial, there is further biographical information on some of the individuals featured at the end of each country section, and on some of the selected firms at the end of each regional chapter. All those selected for inclusion in the IAM Patent 1000 are offered the opportunity to publish this information for a fee – some opt to do so, while others do not. Either way, it has no effect on listing or ranking decisions. The research was conducted entirely independently of any commercial considerations.
Search IAM Patent 1000
China Sinda Intellectual Property Ltd is a leading Chinese private IP firm. As one of the earliest, largest and most prominent Chinese IP law firms, China Sinda Intellectual Property, in conjunction with sister law firm China Sinda Law Offices, provides all aspects of IP and related commercial law services to clients both at home and abroad. We have earned the trust and support of clients since our foundation in 1993. Headquartered in Beijing, we have established branch offices in Washington DC, Tokyo, Munich, Singapore and Hong Kong to meet the needs of our increasing client base. China Sinda has over 260 total staff, including over 70 patent attorneys, 40 technical experts, ...
Potter Clarkson LLP
Ray Charig read physics at Southampton University. He worked for a number of years for a major electronics company in semiconductor device and integrated circuit R&D, before joining Potter Clarkson LLP in 1990. While in industrial R&D, Mr Charig also gained considerable experience in computer-aided manufacturing systems, and he has maintained a particular interest in computer technology, information systems and software applied in a wide range of technical fields, such as telecommunication systems, networks, storage devices, cryptography, medical physics and automation of business processes. Mr Charig is a fellow of the Chartered Institute of Patent Attorneys, a ...
There have been several key legal developments in Canada over the last year. In order to comply with the Patent Treaty, the Canadian Patent Act will be amended, and changes will be made to the law around abandonment and reinstatement of patent applications; it remains to be seen how this will affect the market. Furthermore Bill C-59, when passed, will extend privilege for the first time to Canadian patent agents in regards to confidential communications. This is a welcome development and it is hoped that it will create more opportunities for the agent profession. Practitioners are reporting a fall in pharmaceutical litigation, but noticing a rise in biosimilars legal action, which ...
Register for more free content
- Read more IAM blogs and articles
- Receive the editor's weekly review by email